Ligustrum lucidum Ait. fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21

Oncology Reports

Volumn 32, Issue 3, 2014, Pages 1037-1042

  Hu, Bing ^a   Du, Qin ^a   Deng, Shan ^a   An, Hong Mei ^a   Pan, Chuan Fang ^a   Shen, Ke Ping ^a   Xu, Ling ^a   Wei, Meng Meng ^a   Wang, Shuang Shuang ^a  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Cell senescence; Hepatocellular carcinoma; Ligustrum lucidum fruit; p21

Indexed keywords

BETA GALACTOSIDASE; CASPASE 3; CASPASE 8; CASPASE 9; LIGUSTRUM LUCIDUM EXTRACT; PROTEIN P21; RETINOBLASTOMA PROTEIN; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PEPTIDE CHLOROMETHYL KETONE; PLANT EXTRACT;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL AGING; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; FRUIT; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GENETICS; LIGUSTRUM; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE INHIBITORS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; LIGUSTRUM; LIVER NEOPLASMS; PLANT EXTRACTS;

EID: 84923068178     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3312     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X and Ling C: The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Cancer 115: 5132-5138, 2009.
3. Meng MB, Cui YL, Guan YS, Ying Z, Zheng MH, Yuan CK and Zhang RM: Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. J Altern Complement Med 14: 1027-1042, 2008.
4. Shu X, McCulloch M, Xiao H, Broffman M and Gao J: Chinese herbal medicine and chemotherapy in the treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Integr Cancer Ther 4: 219-229, 2005. (Pubitemid 41153748)
5. Du Q, Hu B, Shen KP and An HM: Pathogenesis and treatment law of Traditional Chinese Medicine in hepatocarcinoma. World J Integr Tradit West Med 5: 814-817, 2010 (In Chinese).
6. Yan JG and Yao SK: The study of TCM syndrome differentiation and treatment in liver cancer. Chin J Integr Tradit West Med Liver Dis 20: 189-190, 2010 (In Chinese).
7. Pan MQ and Tian H: Employ the methods of invigorating spleen and regulating Qi, clearing toxic heat, dissipating stasis and softening hardness to treat primary hepatic cancer. J Tradit Chinese Med 34: 239-240, 1993 (In Chinese).
8. Li YL and Zhang SP: The effects of invigorating spleen and regulating Qi in patients with primary hepatic cancer: an analysis of 127 cases. Tianjin Tradit Chinese Med 17: 12-13, 2000 (In Chinese).
9. Liu Q, Zhang YB, Ma CH, Yue XQ and Ling CQ: Analysis of literature on therapeutic methods and medicines of traditional Chinese medicine for primary liver cancer. Zhong Xi Yi Jie He Xue Bao 3: 260-262, 2005 (In Chinese).
10. Bo X, Zhao XM, Liu HT, Ma WG and Li H: A study on 4 kinds of Chinese medicines reducing arrest of bone marrow by cyclophosphomidum. J Beijing Union Univ (Natural Science) 8: 58-61, 1994 (In Chinese).
11. Zhao YL and Fan WX: The effects of Nü-zhen-zi formula on chemotherapy induced alopecia. Acta Univ Med Nanjing (Natural Science) 24: 305-306, 2004 (In Chinese).
12. Wu XF, Han SY, Zhu LS, Bai J and Liu SM: The effects of Ligustrum lucidum Ait. fruits extract on cyclophosphomidum induced immunosuppression. J North China Coal Med Coll 10: 303-304, 2008 (In Chinese).
13. Shoemaker M, Hamilton B, Dairkee SH, Cohen I and Campbell MJ: In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 19: 649-651, 2005. (Pubitemid 41375251)
14. Jeong JC, Kim JW, Kwon CH, Kim TH and Kim YK: Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in vitro and reduce glioma tumor growth in U87MG xenograft mouse model. Phytother Res 25: 429-434, 2011.
15. Zhang JF, He ML, Qi Dong, Xie WD, Chen YC, Lin MC, Leung PC, Zhang YO and Kung HF: Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression. Integr Cancer Ther 10: 85-91, 2011.
16. Hu B, An HM, Shen KP, Xu L, Du Q, Deng S and Wu Y: Modified Yi Guan Jian, a Chinese herbal formula, induces anoikis in Bel-7402 human hepatocarcinoma cells in vitro. Oncol Rep 26: 1465-1470, 2011.
17. Hu B, Shen KP, An HM, Wu Y and Du Q: Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. Cancer Biother Radiopharm 26: 97-104, 2011.
18. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M and Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367, 1995.
19. Chiantore MV, Vannucchi S, Mangino G, Percario ZA, Affabris E, Fiorucci G and Romeo G: Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr Med Chem 16: 287-300, 2009.
20. Brown JM and Attardi LD: The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5: 231-237, 2005. (Pubitemid 40314954)
21. Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res 63: 2705-2715, 2003.
22. Dimri GP: What has senescence got to do with cancer? Cancer Cell 7: 505-512, 2005.
23. Meier P and Vousden KH: Lucifer's labyrinth - ten years of path finding in cell death. Mol Cell 28: 746-754, 2007. (Pubitemid 350225737)
24. Schmitt CA: Cellular senescence and cancer treatment. Biochim Biophys Acta 1775: 5-20, 2007.
25. Gewirtz DA, Holt SE and Elmore LW: Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76: 947-957, 2008.
26. Nardella C, Clohessy JG, Alimonti A and Pandolfi PP: Pro-sene-scence therapy for cancer treatment. Nat Rev Cancer 11: 503-511, 2011.
27. Di X, Shiu RP, Newsham IF and Gewirtz DA: Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol 77: 1139-1150, 2009.
28. te Poele RH, Okorokov AL, Jardine L, Cummings J and Joel SP: DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876-1883, 2002. (Pubitemid 34408516)
29. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P and Wyche JH: Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 277: 17154-17160, 2002. (Pubitemid 34967748)
30. Kagawa S, Fujiwara T, Kadowaki Y, Fukazawa T, Sok-Joo R, Roth JA and Tanaka N: Overexpression of the p21sdi1 gene induces senescence-like state in human cancer cells: implication for senescence-directed molecular therapy for cancer. Cell Death Differ 6: 765-772, 1999. (Pubitemid 29425387)
31. Ahmad N, Adhami VM, Afaq F, Feyes DK and Mukhtar H: Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7: 1466-1473, 2001. (Pubitemid 32708704)
32. Liu WK, Cheung FW, Liu BP, Li C, Ye W and Che CT: Involvement of p21 and FasL in induction of cell cycle arrest and apoptosis by neochamaejasmin A in human prostate LNCaP cancer cells. J Nat Prod 71: 842-846, 2008. (Pubitemid 351841433)
33. Thaler S, Hähnel PS, Schad A, Dammann R and Schuler M: RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res 69: 1748-1757, 2009.
34. Peng CC, Chen KC, Peng RY, Chyau CC, Su CH and Hsieh-Li HM: Antrodia camphorata extract induces replicative senescence in superficial TCC, and inhibits the absolute migration capability in invasive bladder carcinoma cells. J Ethnopharmacol 109: 93-103, 2007. (Pubitemid 44920191)
35. Wakoh T, Uekawa N, Terauchi K, Sugimoto M, Ishigami A, Shimada J and Maruyama M: Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression. Biochem Biophys Res Commun 380: 807-812, 2009.
36. Lodygin D, Menssen A and Hermeking H: Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner. J Clin Invest 110: 1717-1727, 2002. (Pubitemid 35424250)